COL21A1 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q96P44 |
---|---|
Clone Names | 101008273 |
Gene ID | 81578 |
---|---|
Other Names | Collagen alpha-1(XXI) chain, COL21A1, COL1AL |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | COL21A1 |
---|---|
Synonyms | COL1AL |
Cellular Location | Secreted, extracellular space, extracellular matrix. Cytoplasm. Note=Found in the extracellular matrix component of blood vessel walls and in the cytoplasm of cultured human aortic smooth muscle |
Tissue Location | Highly expressed in lymph node, jejunum, pancreas, stomach, trachea, testis, uterus and placenta; moderately expressed in brain, colon, lung, prostate, spinal cord, salivary gland and vascular smooth-muscle cells and very weakly expressed in heart, liver, kidney, bone marrow, spleen, thymus, skeletal muscle, adrenal gland and peripheral leukocytes. Expression in heart was higher in the right ventricle and atrium than in the left ventricle and atrium |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes the alpha chain of type XXI collagen, amember of the FACIT collagen family (fibril-associated collagenswith interrupted helices). Type XXI collagen is localized totissues containing type I collagen so, like other members of thiscollagen family, it may serve to maintain the integrity of theextracellular matrix. An alternatively spliced transcript varianthas been described, but its full-length nature has yet to bedetermined.
References
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Chou, M.Y., et al. Genomics 79(3):395-401(2002)Tuckwell, D. Matrix Biol. 21(1):63-66(2002)Fitzgerald, J., et al. FEBS Lett. 505(2):275-280(2001)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.